Mauremys mutica isolate MM-2020 ecotype Southern chromosome 21, ASM2049712v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Geoemydidae; Geoemydinae; Mauremys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM035653.1.\nAssembly name: ASM2049712v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Institute of Zoology,\nGuangdong Academy of Science on 2021/10/14. The original\nwhole-genome shotgun project has the accession JAHDVG000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Institute of Zoology, Guangdong Academy\n of Science\nAssembly Method :: FALCON v. March-2021\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 99.81x\nSequencing Technology :: PacBio\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Mauremys mutica Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123354270, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123354270, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123354270, transcript variant X8
uncharacterized LOC123354270, transcript variant X10
uncharacterized LOC123354270, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123354270, transcript variant X7
uncharacterized LOC123354270, transcript variant X6
uncharacterized LOC123354270, transcript variant X11
uncharacterized LOC123354270, transcript variant X5
uncharacterized LOC123354270, transcript variant X1
uncharacterized LOC123354270, transcript variant X3
uncharacterized LOC123354270, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123354273, transcript variant X1
uncharacterized LOC123354273, transcript variant X2
uncharacterized LOC123354271, transcript variant X1
uncharacterized LOC123354271, transcript variant X2
uncharacterized LOC123354269, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123354269, transcript variant X3
uncharacterized LOC123354269, transcript variant X5
uncharacterized LOC123354269, transcript variant X2
uncharacterized LOC123354269, transcript variant X1
solute carrier family 45 member 1, transcript variant X1
solute carrier family 45 member 1, transcript variant X2
proton-associated sugar transporter A isoform X2
proton-associated sugar transporter A isoform X1
Parkinsonism associated deglycase, transcript variant X3
Parkinsonism associated deglycase, transcript variant X2
Parkinsonism associated deglycase, transcript variant X1
TNF receptor superfamily member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TNF receptor superfamily member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 9
uncharacterized LOC123354210, transcript variant X7
uncharacterized LOC123354210, transcript variant X2
uncharacterized LOC123354210, transcript variant X6
uncharacterized LOC123354210, transcript variant X4
uncharacterized LOC123354210, transcript variant X3
uncharacterized LOC123354210, transcript variant X1
uncharacterized LOC123354210, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; substituted 8 bases at 8 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: period circadian protein homolog 3
calmodulin binding transcription activator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
calmodulin-binding transcription activator 1
DnaJ heat shock protein family (Hsp40) member C11, transcript variant X1
dnaJ homolog subfamily C member 11 isoform X1
DnaJ heat shock protein family (Hsp40) member C11, transcript variant X2
dnaJ homolog subfamily C member 11 isoform X2
THAP domain containing 3, transcript variant X6
THAP domain-containing protein 3 isoform X6
THAP domain containing 3, transcript variant X7
THAP domain-containing protein 3 isoform X7
THAP domain containing 3, transcript variant X5
THAP domain-containing protein 3 isoform X5
THAP domain containing 3, transcript variant X4
THAP domain containing 3, transcript variant X2
THAP domain containing 3, transcript variant X3
THAP domain containing 3, transcript variant X1
THAP domain-containing protein 3 isoform X4
THAP domain-containing protein 3 isoform X2
THAP domain-containing protein 3 isoform X3
THAP domain-containing protein 3 isoform X1
kelch like family member 21, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
kelch like family member 21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch like family member 21, transcript variant X2
zinc finger and BTB domain containing 48, transcript variant X3
zinc finger and BTB domain containing 48, transcript variant X1
telomere zinc finger-associated protein isoform X3
telomere zinc finger-associated protein isoform X1
zinc finger and BTB domain containing 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
telomere zinc finger-associated protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleolar protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nucleolar protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
polynucleotide 5'-hydroxyl-kinase NOL9 isoform X1
polynucleotide 5'-hydroxyl-kinase NOL9 isoform X2
pleckstrin homology and RhoGEF domain containing G5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology domain-containing family G member 5 isoform X3
pleckstrin homology and RhoGEF domain containing G5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G5, transcript variant X8
pleckstrin homology and RhoGEF domain containing G5, transcript variant X1
pleckstrin homology and RhoGEF domain containing G5, transcript variant X5
pleckstrin homology domain-containing family G member 5 isoform X1
pleckstrin homology domain-containing family G member 5 isoform X5
pleckstrin homology and RhoGEF domain containing G5, transcript variant X9
pleckstrin homology and RhoGEF domain containing G5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G5, transcript variant X7
pleckstrin homology and RhoGEF domain containing G5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology domain-containing family G member 5 isoform X4
pleckstrin homology and RhoGEF domain containing G5, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain-containing family G member 5 isoform X6
TNF receptor superfamily member 25, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TNF receptor superfamily member 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 25 isoform X1
tumor necrosis factor receptor superfamily member 25 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acyl-CoA thioesterase 7, transcript variant X1
acyl-CoA thioesterase 7, transcript variant X2
cytosolic acyl coenzyme A thioester hydrolase isoform X1
cytosolic acyl coenzyme A thioester hydrolase isoform X2
acyl-CoA thioesterase 7, transcript variant X3
cytosolic acyl coenzyme A thioester hydrolase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
isoprenylcysteine carboxyl methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein-S-isoprenylcysteine O-methyltransferase
chromodomain helicase DNA binding protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromodomain helicase DNA binding protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain helicase DNA binding protein 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromodomain helicase DNA binding protein 5, transcript variant X1
chromodomain helicase DNA binding protein 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromodomain helicase DNA binding protein 5, transcript variant X6
chromodomain helicase DNA binding protein 5, transcript variant X5
chromodomain helicase DNA binding protein 5, transcript variant X8
chromodomain-helicase-DNA-binding protein 5 isoform X1
chromodomain-helicase-DNA-binding protein 5 isoform X2
chromodomain-helicase-DNA-binding protein 5 isoform X4
chromodomain-helicase-DNA-binding protein 5 isoform X3
chromodomain-helicase-DNA-binding protein 5 isoform X5
chromodomain helicase DNA binding protein 5, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 5 isoform X6
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X2
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X6
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X5
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X1
voltage-gated potassium channel subunit beta-2 isoform X3
voltage-gated potassium channel subunit beta-2 isoform X2
voltage-gated potassium channel subunit beta-2 isoform X5
voltage-gated potassium channel subunit beta-2 isoform X4
voltage-gated potassium channel subunit beta-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123354198, transcript variant X2
uncharacterized LOC123354198, transcript variant X1
uncharacterized LOC123354163, transcript variant X2
uncharacterized LOC123354163, transcript variant X1
adherens junctions associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adherens junctions associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adherens junction-associated protein 1 isoform X2
adherens junction-associated protein 1 isoform X1
DNA fragmentation factor subunit beta, transcript variant X2
DNA fragmentation factor subunit beta, transcript variant X1
DNA fragmentation factor subunit beta isoform X1
DNA fragmentation factor subunit beta isoform X2
centrosomal protein 104, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
centrosomal protein 104, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
centrosomal protein 104, transcript variant X4
centrosomal protein of 104 kDa isoform X1
centrosomal protein of 104 kDa isoform X4
centrosomal protein of 104 kDa isoform X2
centrosomal protein 104, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein of 104 kDa isoform X3
leucine-rich repeat-containing protein 47
small integral membrane protein 1 (Vel blood group), transcript variant X6
small integral membrane protein 1 (Vel blood group), transcript variant X5
small integral membrane protein 1 (Vel blood group), transcript variant X7
small integral membrane protein 1 (Vel blood group), transcript variant X3
small integral membrane protein 1 (Vel blood group), transcript variant X4
small integral membrane protein 1 (Vel blood group), transcript variant X2
small integral membrane protein 1 (Vel blood group), transcript variant X1
coiled-coil domain containing 27, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain containing 27, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain containing 27, transcript variant X3
coiled-coil domain containing 27, transcript variant X6
coiled-coil domain containing 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 27, transcript variant X5
coiled-coil domain containing 27, transcript variant X1
coiled-coil domain-containing protein 27 isoform X2
coiled-coil domain-containing protein 27 isoform X4
coiled-coil domain-containing protein 27 isoform X3
coiled-coil domain-containing protein 27 isoform X1
transmembrane cell adhesion receptor mua-3-like, transcript variant X3
transmembrane cell adhesion receptor mua-3-like, transcript variant X2
transmembrane cell adhesion receptor mua-3-like, transcript variant X1
transmembrane cell adhesion receptor mua-3-like, transcript variant X4
uncharacterized protein LOC123354227 isoform X2
uncharacterized protein LOC123354227 isoform X1
transmembrane cell adhesion receptor mua-3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor protein p73, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p73, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p73, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p73, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p73, transcript variant X2
tumor protein p73, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p63-regulated gene 1-like protein
multiple EGF like domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple EGF like domains 6, transcript variant X3
multiple EGF like domains 6, transcript variant X4
multiple epidermal growth factor-like domains protein 6 isoform X2
multiple EGF like domains 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6 isoform X1
multiple epidermal growth factor-like domains protein 6 isoform X3
multiple EGF like domains 6, transcript variant X5
multiple epidermal growth factor-like domains protein 6 isoform X4
multiple EGF like domains 6, transcript variant X9
multiple EGF like domains 6, transcript variant X6
multiple EGF like domains 6, transcript variant X8
multiple EGF like domains 6, transcript variant X10
multiple EGF like domains 6, transcript variant X7
multiple epidermal growth factor-like domains protein 6 isoform X5
multiple epidermal growth factor-like domains protein 6 isoform X6
multiple EGF like domains 6, transcript variant X11
multiple epidermal growth factor-like domains protein 6 isoform X7
Rho guanine nucleotide exchange factor 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho guanine nucleotide exchange factor 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histone-lysine N-methyltransferase PRDM16 isoform X2
histone-lysine N-methyltransferase PRDM16 isoform X1
histone-lysine N-methyltransferase PRDM16 isoform X3
uncharacterized LOC123354444, transcript variant X1
uncharacterized LOC123354444, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 723 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat domain 34, transcript variant X1
tetratricopeptide repeat domain 34, transcript variant X2
tetratricopeptide repeat protein 34 isoform X1
tetratricopeptide repeat protein 34 isoform X2
membrane metalloendopeptidase like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane metalloendopeptidase like 1, transcript variant X3
membrane metalloendopeptidase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane metalloendopeptidase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane metallo-endopeptidase-like 1 isoform X1
membrane metallo-endopeptidase-like 1 isoform X2
membrane metallo-endopeptidase-like 1 isoform X3
tumor necrosis factor receptor superfamily member 14-like, transcript variant X1
tumor necrosis factor receptor superfamily member 14-like, transcript variant X2
tumor necrosis factor receptor superfamily member 14-like, transcript variant X3
tumor necrosis factor receptor superfamily member 14-like isoform X2
tumor necrosis factor receptor superfamily member 14-like isoform X1
tumor necrosis factor receptor superfamily member 14-like isoform X3
tumor necrosis factor receptor superfamily member 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription factor HES-5-like, transcript variant X1
transcription factor HES-5-like, transcript variant X2
transcription factor HES-5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable glutamate receptor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X3
probable glutamate receptor, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2
uncharacterized LOC123354249, transcript variant X2
uncharacterized LOC123354249, transcript variant X1
peroxisomal biogenesis factor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
peroxisomal biogenesis factor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
peroxisome biogenesis factor 10 isoform X1
peroxisome biogenesis factor 10 isoform X2
retention in endoplasmic reticulum sorting receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123354359, transcript variant X1
uncharacterized LOC123354359, transcript variant X3
uncharacterized LOC123354359, transcript variant X2
SKI proto-oncogene, transcript variant X2
SKI proto-oncogene, transcript variant X1
SKI proto-oncogene, transcript variant X3
uncharacterized LOC123354358, transcript variant X2
uncharacterized LOC123354358, transcript variant X1
FA core complex associated protein 20, transcript variant X1
Fanconi anemia core complex-associated protein 20 isoform X1
FA core complex associated protein 20, transcript variant X3
Fanconi anemia core complex-associated protein 20 isoform X3
FA core complex associated protein 20, transcript variant X5
Fanconi anemia core complex-associated protein 20 isoform X5
FA core complex associated protein 20, transcript variant X4
Fanconi anemia core complex-associated protein 20 isoform X4
FA core complex associated protein 20, transcript variant X6
FA core complex associated protein 20, transcript variant X2
Fanconi anemia core complex-associated protein 20 isoform X2
Fanconi anemia core complex-associated protein 20 isoform X6
protein kinase C zeta, transcript variant X2
protein kinase C zeta, transcript variant X3
protein kinase C zeta, transcript variant X4
protein kinase C zeta, transcript variant X6
protein kinase C zeta, transcript variant X1
protein kinase C zeta, transcript variant X7
protein kinase C zeta, transcript variant X5
uncharacterized LOC123354162, transcript variant X1
uncharacterized LOC123354162, transcript variant X3
uncharacterized LOC123354162, transcript variant X2
uncharacterized LOC123354160, transcript variant X3
uncharacterized LOC123354160, transcript variant X1
uncharacterized LOC123354160, transcript variant X2
uncharacterized LOC123354160, transcript variant X4
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X4
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X3
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X1
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X8
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X2
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit delta isoform X2
gamma-aminobutyric acid receptor subunit delta isoform X1
gamma-aminobutyric acid receptor subunit delta isoform X3
gamma-aminobutyric acid receptor subunit delta isoform X4
cilia and flagella associated protein 74, transcript variant X3
cilia and flagella associated protein 74, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X4
cilia and flagella associated protein 74, transcript variant X1
cilia and flagella associated protein 74, transcript variant X2
cilia- and flagella-associated protein 74 isoform X1
cilia- and flagella-associated protein 74 isoform X2
cilia- and flagella-associated protein 74 isoform X4
cilia- and flagella-associated protein 74 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
calmodulin like 6, transcript variant X9
calmodulin like 6, transcript variant X4
calmodulin like 6, transcript variant X6
calmodulin like 6, transcript variant X7
calmodulin like 6, transcript variant X1
calmodulin like 6, transcript variant X3
calmodulin like 6, transcript variant X2
calmodulin like 6, transcript variant X8
calmodulin like 6, transcript variant X5
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
uncharacterized LOC123354195, transcript variant X6
uncharacterized LOC123354195, transcript variant X8
uncharacterized LOC123354195, transcript variant X1
uncharacterized LOC123354195, transcript variant X5
uncharacterized LOC123354195, transcript variant X2
uncharacterized protein LOC123354195 isoform X4
uncharacterized protein LOC123354195 isoform X1
uncharacterized protein LOC123354195 isoform X3
uncharacterized protein LOC123354195 isoform X2
uncharacterized protein LOC123354195 isoform X5
uncharacterized LOC123354195, transcript variant X3
uncharacterized LOC123354195, transcript variant X7
uncharacterized LOC123354195, transcript variant X4
solute carrier family 35 member E2A-like, transcript variant X5
solute carrier family 35 member E2A-like, transcript variant X4
solute carrier family 35 member E2A-like, transcript variant X2
solute carrier family 35 member E2A-like, transcript variant X8
solute carrier family 35 member E2A-like, transcript variant X1
solute carrier family 35 member E2A-like, transcript variant X6
solute carrier family 35 member E2A-like, transcript variant X3
solute carrier family 35 member E2A-like, transcript variant X7
solute carrier family 35 member E2A-like isoform X2
solute carrier family 35 member E2A-like isoform X1
cyclin-dependent kinase 11B, transcript variant X5
cyclin-dependent kinase 11B, transcript variant X3
cyclin-dependent kinase 11B, transcript variant X1
cyclin-dependent kinase 11B, transcript variant X2
cyclin-dependent kinase 11B, transcript variant X4
cyclin-dependent kinase 11B, transcript variant X6
matrix metallopeptidase 23B, transcript variant X2
matrix metallopeptidase 23B, transcript variant X1
MIB E3 ubiquitin protein ligase 2, transcript variant X3
MIB E3 ubiquitin protein ligase 2, transcript variant X1
MIB E3 ubiquitin protein ligase 2, transcript variant X2
E3 ubiquitin-protein ligase MIB2 isoform X2
E3 ubiquitin-protein ligase MIB2 isoform X1
olfactory receptor class A-like protein 4
Golgi integral membrane protein 4-like, transcript variant X2
Golgi integral membrane protein 4-like, transcript variant X1
Golgi integral membrane protein 4-like isoform X1
Golgi integral membrane protein 4-like isoform X2
fibronectin type III domain containing 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
fibronectin type III domain-containing protein 10
SSU72 homolog, RNA polymerase II CTD phosphatase
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
transmembrane protein 240, transcript variant X5
transmembrane protein 240, transcript variant X4
transmembrane protein 240, transcript variant X3
transmembrane protein 240, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 240, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATPase family AAA domain-containing protein 3
von Willebrand factor A domain containing 1, transcript variant X1
von Willebrand factor A domain containing 1, transcript variant X2
von Willebrand factor A domain-containing protein 1 isoform X1
von Willebrand factor A domain-containing protein 1 isoform X2
transmembrane protein 88B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 88B, transcript variant X2
ankyrin repeat domain 65, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ankyrin repeat domain 65, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat domain 65, transcript variant X3
ankyrin repeat domain-containing protein 65 isoform X1
ankyrin repeat domain 65, transcript variant X4
ankyrin repeat domain-containing protein 65 isoform X2
39S ribosomal protein L20, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
matrix remodeling associated 8, transcript variant X1
matrix remodeling associated 8, transcript variant X3
matrix remodeling-associated protein 8 isoform X1
matrix remodeling-associated protein 8 isoform X3
matrix remodeling associated 8, transcript variant X2
matrix remodeling-associated protein 8 isoform X2
dishevelled segment polarity protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dishevelled segment polarity protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dishevelled segment polarity protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
segment polarity protein dishevelled homolog DVL-1 isoform X1
segment polarity protein dishevelled homolog DVL-1 isoform X2
segment polarity protein dishevelled homolog DVL-1 isoform X4
dishevelled segment polarity protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
segment polarity protein dishevelled homolog DVL-1 isoform X3
taste 1 receptor member 3, transcript variant X4
taste 1 receptor member 3, transcript variant X2
taste 1 receptor member 3, transcript variant X3
taste 1 receptor member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
taste receptor type 1 member 3 isoform X1
taste receptor type 1 member 3 isoform X2
ceramide-1-phosphate transfer protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ceramide-1-phosphate transfer protein, transcript variant X2
ceramide-1-phosphate transfer protein isoform X1
ceramide-1-phosphate transfer protein isoform X2
integrator complex subunit 11, transcript variant X2
integrator complex subunit 11, transcript variant X1
lysophosphatidic acid receptor 6-like, transcript variant X2
lysophosphatidic acid receptor 6-like, transcript variant X3
lysophosphatidic acid receptor 6-like, transcript variant X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X4
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X6
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X5
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X6
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X7
sodium channel epithelial 1 subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
amiloride-sensitive sodium channel subunit delta
ubiquitin conjugating enzyme E2 J2, transcript variant X2
ubiquitin conjugating enzyme E2 J2, transcript variant X1
ubiquitin-conjugating enzyme E2 J2 isoform X1
ubiquitin-conjugating enzyme E2 J2 isoform X2
C1q and TNF related 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C1q and TNF related 12, transcript variant X2
stromal cell derived factor 4, transcript variant X2
stromal cell derived factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 18
probable pleckstrin homology domain-containing family N member 1, transcript variant X2
pleckstrin homology domain-containing family N member 1-like isoform X2
probable pleckstrin homology domain-containing family N member 1, transcript variant X1
probable pleckstrin homology domain-containing family N member 1 isoform X1
chromosome 21 C1orf159 homolog, transcript variant X3
chromosome 21 C1orf159 homolog, transcript variant X2
chromosome 21 C1orf159 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome 21 C1orf159 homolog, transcript variant X1
uncharacterized protein C1orf159 homolog
ring finger protein 223, transcript variant X1
ring finger protein 223, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 11-like
hes family bHLH transcription factor 4, transcript variant X2
hes family bHLH transcription factor 4, transcript variant X1
PPARGC1 and ESRR induced regulator, muscle 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
PGC-1 and ERR-induced regulator in muscle protein 1
pleckstrin homology domain containing N1
pleckstrin homology domain-containing family N member 1
kelch like family member 17, transcript variant X7
kelch like family member 17, transcript variant X5
kelch like family member 17, transcript variant X2
kelch like family member 17, transcript variant X6
kelch like family member 17, transcript variant X3
kelch like family member 17, transcript variant X4
kelch like family member 17, transcript variant X1
kelch like family member 17, transcript variant X8
NOC2 like nucleolar associated transcriptional repressor, transcript variant X1
NOC2 like nucleolar associated transcriptional repressor, transcript variant X2
nucleolar complex protein 2 homolog isoform X1
nucleolar complex protein 2 homolog isoform X2
sterile alpha motif domain containing 11, transcript variant X10
sterile alpha motif domain containing 11, transcript variant X3
sterile alpha motif domain containing 11, transcript variant X2
sterile alpha motif domain containing 11, transcript variant X1
sterile alpha motif domain containing 11, transcript variant X4
sterile alpha motif domain containing 11, transcript variant X6
sterile alpha motif domain containing 11, transcript variant X8
sterile alpha motif domain containing 11, transcript variant X7
sterile alpha motif domain containing 11, transcript variant X5
sterile alpha motif domain containing 11, transcript variant X9
sterile alpha motif domain-containing protein 11 isoform X2
sterile alpha motif domain-containing protein 11 isoform X4
sterile alpha motif domain-containing protein 11 isoform X3
sterile alpha motif domain-containing protein 11 isoform X1
sterile alpha motif domain-containing protein 11 isoform X8
sterile alpha motif domain-containing protein 11 isoform X6
sterile alpha motif domain-containing protein 11 isoform X5
sterile alpha motif domain-containing protein 11 isoform X7
uncharacterized LOC123354535, transcript variant X1
uncharacterized LOC123354535, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123354535, transcript variant X3
arginine-glutamic acid dipeptide repeats, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arginine-glutamic acid dipeptide repeats protein isoform X3
arginine-glutamic acid dipeptide repeats, transcript variant X6
arginine-glutamic acid dipeptide repeats, transcript variant X9
arginine-glutamic acid dipeptide repeats, transcript variant X8
arginine-glutamic acid dipeptide repeats, transcript variant X1
arginine-glutamic acid dipeptide repeats, transcript variant X4
arginine-glutamic acid dipeptide repeats, transcript variant X3
arginine-glutamic acid dipeptide repeats, transcript variant X2
arginine-glutamic acid dipeptide repeats, transcript variant X5
arginine-glutamic acid dipeptide repeats, transcript variant X10
arginine-glutamic acid dipeptide repeats protein isoform X2
arginine-glutamic acid dipeptide repeats protein isoform X5
arginine-glutamic acid dipeptide repeats protein isoform X4
arginine-glutamic acid dipeptide repeats protein isoform X1
arginine-glutamic acid dipeptide repeats protein isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2 member 5, transcript variant X2
solute carrier family 2 member 5, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 5 isoform X1
solute carrier family 2, facilitated glucose transporter member 5 isoform X2
G protein-coupled receptor 157, transcript variant X2
G protein-coupled receptor 157, transcript variant X3
G protein-coupled receptor 157, transcript variant X1
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X2
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X1
GDH/6PGL endoplasmic bifunctional protein
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X1
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X3
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X2
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X5
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X4
SPRY domain-containing SOCS box protein 1
solute carrier family 25 member 33, transcript variant X3
solute carrier family 25 member 33, transcript variant X2
solute carrier family 25 member 33 isoform X2
solute carrier family 25 member 33, transcript variant X1
solute carrier family 25 member 33 isoform X1
solute carrier family 25 member 33, transcript variant X5
solute carrier family 25 member 33, transcript variant X4
solute carrier family 25 member 33 isoform X3
solute carrier family 25 member 33 isoform X4
transmembrane protein 201, transcript variant X2
transmembrane protein 201, transcript variant X1
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
leucine zipper and CTNNBIP1 domain containing, transcript variant X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X1
nicotinamide nucleotide adenylyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123354189, transcript variant X2
uncharacterized LOC123354189, transcript variant X4
nicotinamide nucleotide adenylyltransferase 1, transcript variant X2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X1
uncharacterized LOC123354189, transcript variant X3
uncharacterized LOC123354189, transcript variant X1
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X2
ubiquitination factor E4B, transcript variant X1
ubiquitination factor E4B, transcript variant X2
ubiquitin conjugation factor E4 B isoform X1
ubiquitin conjugation factor E4 B isoform X2
uncharacterized LOC123354350, transcript variant X2
uncharacterized LOC123354350, transcript variant X1
kinesin family member 1B, transcript variant X6
kinesin family member 1B, transcript variant X7
kinesin family member 1B, transcript variant X1
kinesin family member 1B, transcript variant X5
kinesin family member 1B, transcript variant X3
kinesin family member 1B, transcript variant X2
kinesin family member 1B, transcript variant X4
6-phosphogluconate dehydrogenase, decarboxylating
centromere protein S-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
centromere protein S-like, transcript variant X1
DNA fragmentation factor subunit alpha, transcript variant X1
DNA fragmentation factor subunit alpha isoform X1
DNA fragmentation factor subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA fragmentation factor subunit alpha isoform X2
peroxisomal biogenesis factor 14, transcript variant X2
peroxisomal biogenesis factor 14, transcript variant X1
peroxisomal membrane protein PEX14 isoform X2
peroxisomal membrane protein PEX14 isoform X1
castor zinc finger 1, transcript variant X6
castor zinc finger 1, transcript variant X4
castor zinc finger 1, transcript variant X10
castor zinc finger 1, transcript variant X3
castor zinc finger 1, transcript variant X5
castor zinc finger 1, transcript variant X8
castor zinc finger 1, transcript variant X7
castor zinc finger 1, transcript variant X9
castor zinc finger 1, transcript variant X1
castor zinc finger 1, transcript variant X11
castor zinc finger 1, transcript variant X2
zinc finger protein castor homolog 1 isoform X3
zinc finger protein castor homolog 1 isoform X4
zinc finger protein castor homolog 1 isoform X1
zinc finger protein castor homolog 1 isoform X2
zinc finger protein castor homolog 1 isoform X5
castor zinc finger 1, transcript variant X12
zinc finger protein castor homolog 1 isoform X6
TAR DNA binding protein, transcript variant X2
TAR DNA binding protein, transcript variant X1
MBL associated serine protease 2, transcript variant X2
MBL associated serine protease 2, transcript variant X1
mannan-binding lectin serine protease 2 isoform X1
mannan-binding lectin serine protease 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
exosome component 10, transcript variant X2
exosome component 10, transcript variant X1
mechanistic target of rapamycin kinase, transcript variant X2
mechanistic target of rapamycin kinase, transcript variant X1
serine/threonine-protein kinase mTOR isoform X2
serine/threonine-protein kinase mTOR isoform X1
UbiA prenyltransferase domain containing 1, transcript variant X1
UbiA prenyltransferase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiA prenyltransferase domain-containing protein 1
dispatched RND transporter family member 3, transcript variant X1
dispatched RND transporter family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
F-box only protein 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
F-box only protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitotic arrest deficient 2 like 2, transcript variant X2
mitotic arrest deficient 2 like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
mitotic spindle assembly checkpoint protein MAD2B isoform X2
mitotic spindle assembly checkpoint protein MAD2B isoform X1
dorsal inhibitory axon guidance protein, transcript variant X2
dorsal inhibitory axon guidance protein, transcript variant X1
angiotensin II receptor associated protein, transcript variant X5
type-1 angiotensin II receptor-associated protein isoform X5
angiotensin II receptor associated protein, transcript variant X4
type-1 angiotensin II receptor-associated protein isoform X4
angiotensin II receptor associated protein, transcript variant X1
angiotensin II receptor associated protein, transcript variant X2
type-1 angiotensin II receptor-associated protein isoform X2
type-1 angiotensin II receptor-associated protein isoform X1
angiotensin II receptor associated protein, transcript variant X3
type-1 angiotensin II receptor-associated protein isoform X3
chromosome 21 C1orf167 homolog, transcript variant X1
chromosome 21 C1orf167 homolog, transcript variant X2
chromosome 21 C1orf167 homolog, transcript variant X7
chromosome 21 C1orf167 homolog, transcript variant X4
chromosome 21 C1orf167 homolog, transcript variant X3
chromosome 21 C1orf167 homolog, transcript variant X6
chromosome 21 C1orf167 homolog, transcript variant X5
uncharacterized protein C1orf167 homolog isoform X1
uncharacterized protein C1orf167 homolog isoform X2
uncharacterized protein C1orf167 homolog isoform X4
uncharacterized protein C1orf167 homolog isoform X3
uncharacterized protein C1orf167 homolog isoform X6
uncharacterized protein C1orf167 homolog isoform X5
uncharacterized protein C1orf167 homolog isoform X7
methylenetetrahydrofolate reductase, transcript variant X1
methylenetetrahydrofolate reductase, transcript variant X2
methylenetetrahydrofolate reductase isoform X1
methylenetetrahydrofolate reductase isoform X2
chloride voltage-gated channel 6, transcript variant X1
chloride voltage-gated channel 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
receptor-type guanylate cyclase gcy-22-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA2013 homolog
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, transcript variant X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, transcript variant X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
migration and invasion inhibitory protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
migration and invasion inhibitory protein, transcript variant X2
migration and invasion-inhibitory protein isoform X2
migration and invasion inhibitory protein, transcript variant X4
migration and invasion inhibitory protein, transcript variant X1
migration and invasion-inhibitory protein isoform X1
migration and invasion-inhibitory protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 8
TNF receptor superfamily member 1B, transcript variant X2
TNF receptor superfamily member 1B, transcript variant X3
TNF receptor superfamily member 1B, transcript variant X4
TNF receptor superfamily member 1B, transcript variant X1
tumor necrosis factor receptor superfamily member 1B isoform X1
tumor necrosis factor receptor superfamily member 1B isoform X2
tumor necrosis factor receptor superfamily member 1B isoform X3
tumor necrosis factor receptor superfamily member 1B isoform X4
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
vacuolar protein sorting-associated protein 13D
dehydrogenase/reductase 3, transcript variant X1
dehydrogenase/reductase 3, transcript variant X2
dehydrogenase/reductase 3, transcript variant X3
short-chain dehydrogenase/reductase 3 isoform X1
short-chain dehydrogenase/reductase 3 isoform X2
short-chain dehydrogenase/reductase 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 107
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C1orf158 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat-containing protein 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123354181, transcript variant X2
uncharacterized LOC123354181, transcript variant X1
uncharacterized LOC123354181, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PR domain zinc finger protein 2 isoform X1
PR domain zinc finger protein 2 isoform X3
PR domain zinc finger protein 2 isoform X2
PR domain zinc finger protein 2 isoform X4
kazrin, periplakin interacting protein, transcript variant X1
kazrin, periplakin interacting protein, transcript variant X3
kazrin, periplakin interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: transmembrane protein 51
forkhead associated phosphopeptide binding domain 1, transcript variant X2
forkhead associated phosphopeptide binding domain 1, transcript variant X1
forkhead associated phosphopeptide binding domain 1, transcript variant X4
forkhead associated phosphopeptide binding domain 1, transcript variant X3
forkhead associated phosphopeptide binding domain 1, transcript variant X5
forkhead-associated domain-containing protein 1 isoform X1
forkhead-associated domain-containing protein 1 isoform X3
forkhead-associated domain-containing protein 1 isoform X2
forkhead-associated domain-containing protein 1 isoform X4
chymotrypsin-C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chymotrypsin-C-like, transcript variant X2
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X3
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X2
dnaJ homolog subfamily C member 16 isoform X2
dnaJ homolog subfamily C member 16 isoform X1
serine/threonine-protein kinase PINK1, mitochondrial
cytidine deaminase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytidine deaminase, transcript variant X6
cytidine deaminase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytidine deaminase, transcript variant X4
cytidine deaminase, transcript variant X1
cytidine deaminase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 43 member B, transcript variant X2
family with sequence similarity 43 member B, transcript variant X1
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X4
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X3
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X2
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X1
mitochondrial ubiquitin ligase activator of NFKB 1
calcium/calmodulin dependent protein kinase II inhibitor 1
calcium/calmodulin-dependent protein kinase II inhibitor 1
von Willebrand factor A domain containing 5B1, transcript variant X2
von Willebrand factor A domain containing 5B1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain-containing protein 5B1 isoform X1
von Willebrand factor A domain-containing protein 5B1 isoform X2
ATP-dependent RNA helicase DDX19B, transcript variant X1
ATP-dependent RNA helicase DDX19B isoform X1
ATP-dependent RNA helicase DDX19B, transcript variant X2
ATP-dependent RNA helicase DDX19B isoform X2
UBX domain protein 10, transcript variant X9
UBX domain protein 10, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UBX domain protein 10, transcript variant X5
UBX domain protein 10, transcript variant X3
UBX domain protein 10, transcript variant X4
UBX domain protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
UBX domain protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UBX domain protein 10, transcript variant X6
UBX domain protein 10, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
group IIF secretory phospholipase A2-like
basic phospholipase A2 homolog Gln49-PLA2-like
group IIE secretory phospholipase A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 186, transcript variant X7
ring finger protein 186, transcript variant X8
ring finger protein 186, transcript variant X4
ring finger protein 186, transcript variant X5
ring finger protein 186, transcript variant X6
ring finger protein 186, transcript variant X2
ring finger protein 186, transcript variant X1
ring finger protein 186, transcript variant X3
transmembrane and coiled-coil domains 4, transcript variant X1
transmembrane and coiled-coil domains 4, transcript variant X3
transmembrane and coiled-coil domains 4, transcript variant X2
transmembrane and coiled-coil domain-containing protein 4 isoform X1
transmembrane and coiled-coil domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
neuroblastoma suppressor of tumorigenicity 1, transcript variant X1
neuroblastoma suppressor of tumorigenicity 1, transcript variant X2
neuroblastoma suppressor of tumorigenicity 1 isoform X1
neuroblastoma suppressor of tumorigenicity 1 isoform X2
mitochondrial contact site and cristae organizing system subunit 10
capping actin protein of muscle Z-line subunit beta, transcript variant X1
capping actin protein of muscle Z-line subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
F-actin-capping protein subunit beta isoform X1
lysosomal amino acid transporter 1 homolog
aflatoxin B1 aldehyde reductase member 2
MRT4 homolog, ribosome maturation factor
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1 isoform X1
ER membrane protein complex subunit 1 isoform X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X1
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X4
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X3
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X7
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X5
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X6
E3 ubiquitin-protein ligase UBR4 isoform X1
E3 ubiquitin-protein ligase UBR4 isoform X4
E3 ubiquitin-protein ligase UBR4 isoform X3
E3 ubiquitin-protein ligase UBR4 isoform X7
E3 ubiquitin-protein ligase UBR4 isoform X2
E3 ubiquitin-protein ligase UBR4 isoform X5
E3 ubiquitin-protein ligase UBR4 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aldehyde dehydrogenase 4 family member A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
immunoglobin superfamily member 21, transcript variant X3
immunoglobin superfamily member 21, transcript variant X4
immunoglobin superfamily member 21, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobin superfamily member 21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
immunoglobulin superfamily member 21 isoform X1
immunoglobulin superfamily member 21 isoform X2
immunoglobulin superfamily member 21 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 647 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 10 like, transcript variant X2
Rho guanine nucleotide exchange factor 10 like, transcript variant X4
Rho guanine nucleotide exchange factor 10 like, transcript variant X3
Rho guanine nucleotide exchange factor 10 like, transcript variant X1
rho guanine nucleotide exchange factor 10-like protein isoform X4
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein isoform X2
regulator of chromosome condensation 2, transcript variant X1
regulator of chromosome condensation 2, transcript variant X2
regulator of chromosome condensation 2, transcript variant X4
regulator of chromosome condensation 2, transcript variant X3
protein-arginine deiminase type-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein-arginine deiminase type-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein-arginine deiminase type-3-like isoform X1
protein-arginine deiminase type-3-like isoform X2
protein-arginine deiminase type-2-like, transcript variant X4
protein-arginine deiminase type-2-like, transcript variant X3
protein-arginine deiminase type-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
protein-arginine deiminase type-2-like, transcript variant X6
protein-arginine deiminase type-2-like, transcript variant X1
protein-arginine deiminase type-2-like, transcript variant X2
protein-arginine deiminase type-2-like isoform X1
protein-arginine deiminase type-2-like isoform X2
protein-arginine deiminase type-2-like isoform X3
succinate dehydrogenase complex iron sulfur subunit B
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
ATPase cation transporting 13A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
polyamine-transporting ATPase 13A2 isoform X1
ATPase cation transporting 13A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polyamine-transporting ATPase 13A2 isoform X2
microfibril associated protein 2, transcript variant X3
microfibril associated protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
microfibril associated protein 2, transcript variant X1
microfibril associated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
microfibrillar-associated protein 2 isoform X1
microfibrillar-associated protein 2 isoform X2
microfibrillar-associated protein 2 isoform X3
microfibrillar-associated protein 2 isoform X4
ciliary rootlet coiled-coil, rootletin, transcript variant X6
ciliary rootlet coiled-coil, rootletin, transcript variant X2
ciliary rootlet coiled-coil, rootletin, transcript variant X4
ciliary rootlet coiled-coil, rootletin, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X7
ciliary rootlet coiled-coil, rootletin, transcript variant X8
ciliary rootlet coiled-coil, rootletin, transcript variant X9
NECAP endocytosis associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
NECAP endocytosis associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
adaptin ear-binding coat-associated protein 2 isoform X1
adaptin ear-binding coat-associated protein 2 isoform X2
SUZ RNA binding domain containing 1, transcript variant X4
SUZ RNA binding domain containing 1, transcript variant X3
SUZ RNA binding domain containing 1, transcript variant X1
SUZ RNA binding domain containing 1, transcript variant X2
SUZ domain-containing protein 1 isoform X4
SUZ domain-containing protein 1 isoform X3
SUZ domain-containing protein 1 isoform X1
SUZ domain-containing protein 1 isoform X2
uncharacterized LOC123354268, transcript variant X1
uncharacterized LOC123354268, transcript variant X3
uncharacterized LOC123354268, transcript variant X2
ciliogenesis and planar polarity effector 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2, transcript variant X3
ciliogenesis and planar polarity effector 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Rho guanine nucleotide exchange factor 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho guanine nucleotide exchange factor 19-like, transcript variant X1
rho guanine nucleotide exchange factor 19-like, transcript variant X2
rho guanine nucleotide exchange factor 19-like, transcript variant X3
rho guanine nucleotide exchange factor 19-like isoform X1
rho guanine nucleotide exchange factor 19-like isoform X2
rho guanine nucleotide exchange factor 19-like isoform X3
family with sequence similarity 131 member C
chloride channel protein ClC-Kb-like, transcript variant X1
chloride channel protein ClC-Kb-like, transcript variant X3
chloride channel protein ClC-Kb-like, transcript variant X4
chloride channel protein ClC-Kb-like, transcript variant X2
chloride channel protein ClC-Kb-like isoform X2
chloride channel protein ClC-Kb-like isoform X1
heat shock protein family B (small) member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 17, transcript variant X1
zinc finger and BTB domain containing 17, transcript variant X2
zinc finger and BTB domain-containing protein 17 isoform X1
zinc finger and BTB domain-containing protein 17 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
filamin binding LIM protein 1, transcript variant X2
filamin binding LIM protein 1, transcript variant X1
filamin binding LIM protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pleckstrin homology and RUN domain containing M2, transcript variant X1
pleckstrin homology and RUN domain containing M2, transcript variant X2
pleckstrin homology and RUN domain containing M2, transcript variant X3
pleckstrin homology domain-containing family M member 2 isoform X1
pleckstrin homology domain-containing family M member 2 isoform X3
pleckstrin homology domain-containing family M member 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
regulatory solute carrier protein family 1 member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kelch-like protein 6, transcript variant X2
kelch-like protein 6, transcript variant X3
kelch-like protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lactamase beta like 1, transcript variant X1
lactamase beta like 1, transcript variant X2
putative beta-lactamase-like 1 isoform X1
putative beta-lactamase-like 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transfer RNA isoleucine (anticodon GAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123354224, transcript variant X2
uncharacterized LOC123354224, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123354250, transcript variant X1
uncharacterized LOC123354250, transcript variant X2
zinc finger and BTB domain containing 40, transcript variant X5
zinc finger and BTB domain containing 40, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger and BTB domain containing 40, transcript variant X4
zinc finger and BTB domain containing 40, transcript variant X1
zinc finger and BTB domain containing 40, transcript variant X2
zinc finger and BTB domain-containing protein 40 isoform X4
zinc finger and BTB domain-containing protein 40 isoform X2
zinc finger and BTB domain-containing protein 40 isoform X3
zinc finger and BTB domain-containing protein 40 isoform X1
Wnt family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Wnt family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Wnt family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Wnt family member 4, transcript variant X6
Wnt family member 4, transcript variant X3
Wnt family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle 42, transcript variant X1
cell division control protein 42 homolog isoform X1
cell division cycle 42, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cell division control protein 42 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
Y-box binding protein 1, transcript variant X2
Y-box binding protein 1, transcript variant X1
Y-box binding protein 1, transcript variant X3
coiled-coil domain containing 30, transcript variant X2
coiled-coil domain containing 30, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 30, transcript variant X1
coiled-coil domain containing 30, transcript variant X4
coiled-coil domain containing 30, transcript variant X5
coiled-coil domain containing 30, transcript variant X6
coiled-coil domain containing 30, transcript variant X7
coiled-coil domain-containing protein 30 isoform X2
coiled-coil domain-containing protein 30 isoform X3
coiled-coil domain-containing protein 30 isoform X1
coiled-coil domain-containing protein 30 isoform X4
coiled-coil domain-containing protein 30 isoform X5
coiled-coil domain-containing protein 30 isoform X6
phosphopantothenoylcysteine synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphopantothenoylcysteine synthetase, transcript variant X3
phosphopantothenoylcysteine synthetase, transcript variant X2
phosphopantothenoylcysteine synthetase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphopantothenoylcysteine synthetase, transcript variant X4
phosphopantothenoylcysteine synthetase, transcript variant X5
phosphopantothenate--cysteine ligase isoform X2
phosphopantothenate--cysteine ligase isoform X1
phosphopantothenate--cysteine ligase isoform X3
zinc finger MYND-type containing 12, transcript variant X1
zinc finger MYND domain-containing protein 12 isoform X1
zinc finger MYND-type containing 12, transcript variant X2
zinc finger MYND domain-containing protein 12 isoform X2
solute carrier family 2 member 1, transcript variant X2
solute carrier family 2 member 1, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 1 isoform X2
solute carrier family 2, facilitated glucose transporter member 1 isoform X1
polyhomeotic homolog 2, transcript variant X2
polyhomeotic homolog 2, transcript variant X3
polyhomeotic homolog 2, transcript variant X12
polyhomeotic homolog 2, transcript variant X11
polyhomeotic homolog 2, transcript variant X10
polyhomeotic homolog 2, transcript variant X7
polyhomeotic homolog 2, transcript variant X1
polyhomeotic homolog 2, transcript variant X5
polyhomeotic homolog 2, transcript variant X6
polyhomeotic homolog 2, transcript variant X8
polyhomeotic homolog 2, transcript variant X4
polyhomeotic homolog 2, transcript variant X9
polyhomeotic homolog 2, transcript variant X13
polyhomeotic homolog 2, transcript variant X14
zinc finger protein 362, transcript variant X5
zinc finger protein 362, transcript variant X11
zinc finger protein 362, transcript variant X10
zinc finger protein 362, transcript variant X15
zinc finger protein 362, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 362, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 362, transcript variant X7
zinc finger protein 362, transcript variant X13
zinc finger protein 362, transcript variant X3
zinc finger protein 362, transcript variant X12
zinc finger protein 362, transcript variant X17
zinc finger protein 362, transcript variant X2
zinc finger protein 362, transcript variant X6
zinc finger protein 362, transcript variant X16
zinc finger protein 362, transcript variant X4
zinc finger protein 362, transcript variant X8
zinc finger protein 362, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 2
transmembrane protein 269, transcript variant X5
transmembrane protein 269, transcript variant X1
transmembrane protein 269, transcript variant X7
transmembrane protein 269, transcript variant X4
transmembrane protein 269, transcript variant X2
transmembrane protein 269, transcript variant X6
transmembrane protein 269, transcript variant X8
transmembrane protein 269, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-like elastase family member 3B
heparan sulfate proteoglycan 2, transcript variant X1
heparan sulfate proteoglycan 2, transcript variant X2
heparan sulfate proteoglycan 2, transcript variant X4
heparan sulfate proteoglycan 2, transcript variant X5
heparan sulfate proteoglycan 2, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein isoform X5
basement membrane-specific heparan sulfate proteoglycan core protein isoform X3
low density lipoprotein receptor class A domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
low-density lipoprotein receptor class A domain-containing protein 2
ubiquitin specific peptidase 48, transcript variant X1
ubiquitin specific peptidase 48, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 48 isoform X1
ubiquitin carboxyl-terminal hydrolase 48 isoform X2
RAP1 GTPase activating protein, transcript variant X3
RAP1 GTPase activating protein, transcript variant X1
RAP1 GTPase activating protein, transcript variant X2
rap1 GTPase-activating protein 1 isoform X1
rap1 GTPase-activating protein 1 isoform X2
rap1 GTPase-activating protein 1 isoform X3
alkaline phosphatase, biomineralization associated, transcript variant X1
alkaline phosphatase, biomineralization associated, transcript variant X2
alkaline phosphatase, tissue-nonspecific isozyme
endothelin converting enzyme 1, transcript variant X2
endothelin-converting enzyme 1 isoform X2
endothelin converting enzyme 1, transcript variant X1
endothelin-converting enzyme 1 isoform X1
eukaryotic translation initiation factor 4 gamma 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X6
eukaryotic translation initiation factor 4 gamma 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X2
eukaryotic translation initiation factor 4 gamma 3, transcript variant X4
eukaryotic translation initiation factor 4 gamma 3, transcript variant X10
eukaryotic translation initiation factor 4 gamma 3, transcript variant X5
eukaryotic translation initiation factor 4 gamma 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X8
eukaryotic translation initiation factor 4 gamma 3, transcript variant X13
eukaryotic translation initiation factor 4 gamma 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3 isoform X1
eukaryotic translation initiation factor 4 gamma 3 isoform X6
eukaryotic translation initiation factor 4 gamma 3 isoform X3
eukaryotic translation initiation factor 4 gamma 3 isoform X9
eukaryotic translation initiation factor 4 gamma 3 isoform X2
eukaryotic translation initiation factor 4 gamma 3 isoform X4
eukaryotic translation initiation factor 4 gamma 3 isoform X10
eukaryotic translation initiation factor 4 gamma 3 isoform X5
eukaryotic translation initiation factor 4 gamma 3 isoform X12
eukaryotic translation initiation factor 4 gamma 3 isoform X7
eukaryotic translation initiation factor 4 gamma 3 isoform X8
eukaryotic translation initiation factor 4 gamma 3 isoform X13
eukaryotic translation initiation factor 4 gamma 3 isoform X14
eukaryotic translation initiation factor 4 gamma 3 isoform X11
heterochromatin protein 1 binding protein 3, transcript variant X8
heterochromatin protein 1 binding protein 3, transcript variant X6
heterochromatin protein 1 binding protein 3, transcript variant X4
heterochromatin protein 1 binding protein 3, transcript variant X5
heterochromatin protein 1 binding protein 3, transcript variant X1
heterochromatin protein 1 binding protein 3, transcript variant X2
heterochromatin protein 1 binding protein 3, transcript variant X3
heterochromatin protein 1 binding protein 3, transcript variant X7
heterochromatin protein 1 binding protein 3, transcript variant X9
heterochromatin protein 1-binding protein 3 isoform X1
heterochromatin protein 1-binding protein 3 isoform X4
heterochromatin protein 1-binding protein 3 isoform X2
heterochromatin protein 1-binding protein 3 isoform X5
heterochromatin protein 1-binding protein 3 isoform X3
heterochromatin protein 1-binding protein 3 isoform X6
heterochromatin protein 1-binding protein 3 isoform X7
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon AAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
maestro heat-like repeat family member 5, transcript variant X2
maestro heat-like repeat family member 5, transcript variant X1
maestro heat-like repeat family member 5
uncharacterized LOC123354418, transcript variant X1
uncharacterized LOC123354418, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon ACU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123354479, transcript variant X3
uncharacterized LOC123354479, transcript variant X2
uncharacterized LOC123354479, transcript variant X1
uncharacterized LOC123354538, transcript variant X2
uncharacterized LOC123354538, transcript variant X1
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
class I histocompatibility antigen, F10 alpha chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
class I histocompatibility antigen, F10 alpha chain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
class I histocompatibility antigen, F10 alpha chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
class I histocompatibility antigen, F10 alpha chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
class I histocompatibility antigen, F10 alpha chain-like, transcript variant X5
class I histocompatibility antigen, F10 alpha chain-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
adhesion G protein-coupled receptor E1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adhesion G protein-coupled receptor E1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
CCAAT/enhancer-binding protein gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
CCAAT/enhancer-binding protein gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CCAAT/enhancer-binding protein gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns